Cooperative Agreement U54CA302465
Award Date 9/5/25
Completion Date 6/30/30
Dollars Obligated $2.3M
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Florida, USA
Similar Awards
- This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports the development, piloting, and evaluation of an innovative skills training program to educate current women's health, infectious disease, and colorectal providers on anal cancer screening for high-risk patient populations. The $165,271 award to Emory University aims to leverage the institution's expertise in online/distance-based education for mid-career professionals, as well as its...
- The University of Miami was awarded a $674,440 Project Grant from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) on February 3, 2025. The grant is titled "Myeloma Defining Genomic Events to Differentiate Benign and Malignant Myeloma Precursor Conditions" and runs through January 31, 2030. The project aims to comprehensively define the clinical impact of the genomic events that differentiate progressive from stable myeloma precursor conditions, leveraging...
- The University of Miami was awarded a $538,553 federal Project Grant from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to conduct longitudinal research on the use of quantitative multiparametric MRI (mpMRI) features and circulating tumor cells (CTCs) as early markers of treatment outcomes for prostate cancer patients receiving radiotherapy and androgen deprivation therapy (ADT). The goal of the 5-year research project is to define the role of mpMRI and...
- This $1,386,091 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) is funding a research project at the University of Miami to study awareness and knowledge of endometrial cancer among subpopulations of Black women. The project will be conducted over a performance period from July 1, 2024 to June 30, 2027. As a prominent academic medical center, the University of Miami has extensive experience executing federally-funded...
- This $5,041,790 cooperative agreement award from the National Cancer Institute (NCI), under the Cancer Centers Support Grants program (CFDA 93.397), will fund research projects at the University of California, San Francisco (UCSF) to improve cancer health disparities. The key products and services to be delivered include: Three translational cancer health disparities research projects focused on meningioma, prostate cancer, and breast cancer. The projects aim to evaluate the interplay of...
- The National Cancer Institute (NCI) awarded a $753,446 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Boston Medical Center Corporation (BMC) to develop and evaluate an intervention to improve cervical cancer screening and follow-up in underserved populations. The intervention, known as DOSE-CC, combines education and quality improvement methods to help clinicians enhance their cervical cancer prevention practices. The goal is to adapt BMC's prior...
- The University of Alabama at Birmingham (UAB) received a $192,780 Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) to implement and optimize a bundled screening program for breast and cervical cancer in a resource-limited setting in sub-Saharan Africa. The project aims to 1) establish the reach and effectiveness of the bundled screening program across stationary and mobile clinics, and 2) identify the implementation outcomes of...
- The National Cancer Institute (NCI) awarded a $851,463 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. The grant, awarded on September 1, 2025, will fund a 5-year research project to leverage electronic health record (EHR) data and community partnerships to understand the impacts of HIV and cancer stigma on cancer care delivery for people living with HIV in the Southeastern United States....
- The University of Miami was awarded a $447,340 Project Grant from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395) to identify epigenetic vulnerabilities in endocrine-resistant breast cancer. The 5-year project aims to investigate the role of the CoREST-SWI/SNF axis in regulating breast cancer cell plasticity and endocrine therapy resistance, with a focus on overcoming resistance mediated by loss of estrogen receptor expression. The research seeks to...
- This $2,991,283 Project Grant was awarded on September 23, 2025 by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Florida. The grant will fund a two-pronged research approach to (1) leverage a large electronic health record database to characterize trends and outcomes of lung cancer screening among people with and without HIV in the U.S., and (2) partner with community clinics serving...